Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2020-01-20 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
关于调整2019年限制性股票激励计划相关事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding adjustments to the 2019 restricted stock incentive plan of Wuxi Xiangsheng Medical Technology Co., Ltd. It details board and supervisory approvals, independent director opinions, and legal opinions on the stock incentive plan adjustments. The content focuses on changes to the equity incentive plan, including the total amount of restricted stock granted and related procedural compliance. There are no financial statements or comprehensive financial performance data presented. The document is a formal announcement of changes to a stock incentive plan, which fits best under the category of Capital/Financing Update (CAP), as it relates to equity incentives and capital structure adjustments rather than a full report or regulatory filing.
2020-01-20 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司2019年度持续督导现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2019年度持续督导现场检查报告" which translates to "2019 Annual Continuous Supervision On-site Inspection Report" by the sponsoring institution (国金证券股份有限公司) for a company listed on the STAR Market (科创板). The content details the on-site inspection covering governance, internal controls, information disclosure, independence, use of raised funds, related party transactions, guarantees, major investments, and operational status. It is a detailed report of the sponsor's continuous supervision activities during a specific period in 2019. The document is about a regulatory on-site inspection report rather than a full annual report or audit report. It is not a brief announcement or a certification letter but a substantive report on the sponsor's supervisory findings. This type of document aligns best with the category of Audit Report / Information (AR), as it is a standalone inspection report related to regulatory compliance and internal controls, not the full annual report (10-K) or other categories. The document length is under 5,000 characters but contains detailed substantive content, so it is not a mere announcement (RPA) or regulatory filing (RNS). Therefore, the classification is AR with high confidence. FY 2019
2020-01-17 Chinese
关于公司2019年限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告
Regulatory Filings Classification · 95% confidence The document is a self-inspection report regarding insider trading and stock transactions related to a 2019 restricted stock incentive plan by Wuxi Xiangsheng Medical Technology Co., Ltd. It details the scope and procedures of the investigation, confirms no insider trading occurred, and concludes compliance with disclosure and confidentiality regulations. The document is not a financial report, earnings release, or management discussion, nor is it an announcement of voting results or a proxy statement. It is a regulatory disclosure related to insider information and compliance with stock incentive plan rules. Given the nature and content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-01-17 Chinese
2020年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 second extraordinary shareholders' meeting of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes information about the meeting date, location, attendance, voting results on specific proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance of the shareholders' meeting rather than presenting financial data or management discussion. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2362 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2020-01-17 Chinese
2020年第二次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2020 second extraordinary shareholders' meeting of Wuxi Xiangsheng Medical Technology Co., Ltd. It discusses the legality of the meeting's convening, attendance, voting procedures, and results. It is not a financial report, earnings release, or management discussion. It is also not a notice of voting results but a legal opinion supporting the meeting's procedures and results. The document is relatively short (2448 characters) and serves as a legal opinion related to a shareholders' meeting. This type of document does not fit into categories like Annual Report, Earnings Release, or Proxy Solicitation. It is best classified under Regulatory Filings (RNS) as a general regulatory/legal filing that does not fit other categories.
2020-01-17 Chinese
2020年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2020 Second Extraordinary General Meeting of Shareholders" of Wuxi Xiangsheng Medical Technology Co., Ltd. It contains detailed meeting instructions, agenda, and proposals to be voted on during the shareholders' meeting. The content includes procedural rules, voting instructions, and specific proposals related to stock incentive plans. There is no financial data or earnings information, nor is it a transcript of a call or a report publication announcement. The document is clearly the materials shared for a shareholders' meeting, which fits the definition of AGM Information (AGM-R). The document length (6068 characters) and detailed meeting agenda support this classification with high confidence.
2020-01-08 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.